Ownership history in WOLVERINE ASSET MANAGEMENT LLC · 27 quarters on record
This page tracks every 13F SEC filing in which WOLVERINE ASSET MANAGEMENT LLC reported a position in ESPERION THERAPEUTICS INC NE (ESPR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 88,906 | — | 0% | 0.00% | $236K | $2.65 |
| 2025 Q2 | UNCHANGED | 88,906 | — | 0% | 0.00% | $88K | $0.98 |
| 2025 Q1 | ADDED | 88,906 | +1,522 | +1.7% | 0.00% | $128K | $1.44 |
| 2024 Q4 | UNCHANGED | 87,384 | — | 0% | 0.00% | $192K | $2.20 |
| 2024 Q3 | UNCHANGED | 87,384 | — | 0% | 0.00% | $144K | $1.65 |
| 2024 Q2 | UNCHANGED | 87,384 | — | 0% | 0.00% | $194K | $2.22 |
| 2024 Q1 | UNCHANGED | 87,384 | — | 0% | 0.00% | $234K | $2.68 |
| 2023 Q4 | ADDED | 87,384 | +87,184 | +43592.0% | 0.00% | $261K | $2.99 |
| 2023 Q3 | REDUCED | 200 | -87,184 | -99.8% | 0.00% | $196 | $0.98 |
| 2023 Q3 | ADDED | 87,384 | +87,184 | +43592.0% | 0.00% | $86K | $0.98 |
As of 2025 Q4 — sorted by position size